A carregar...

CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype

CYP2C19 is a drug-metabolising enzyme involved in the metabolism of a number of chemotherapeutic agents including cyclophosphamide. Variants of the CYP2C19 gene result in a loss of function polymorphism, which affects approximately 3% of the Caucasian population. These individuals are poor metabolis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Helsby, N A, Lo, W-Y, Sharples, K, Riley, G, Murray, M, Spells, K, Dzhelai, M, Simpson, A, Findlay, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2570511/
https://ncbi.nlm.nih.gov/pubmed/18854824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604699
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!